no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Foreword
|
Standl, E. |
|
2003 |
46 |
supplement-1 |
p. M1 |
article |
2 |
Foreword
|
Standl, E. |
|
2003 |
46 |
supplement-1 |
p. M1 |
article |
3 |
Loss of early insulin secretion leads to postprandial hyperglycaemia
|
Del Prato, S. |
|
2003 |
46 |
supplement-1 |
p. M2-M8 |
article |
4 |
Loss of early insulin secretion leads to postprandial hyperglycaemia
|
Del Prato, S. |
|
2003 |
46 |
supplement-1 |
p. M2-M8 |
article |
5 |
Pharmacologic restoration of the early insulin response in pre-diabetic monkeys controls mealtime glucose excursions without peripheral hyperinsulinaemia
|
Dunning, B. |
|
2003 |
46 |
supplement-1 |
p. M22-M29 |
article |
6 |
Pharmacologic restoration of the early insulin response in pre-diabetic monkeys controls mealtime glucose excursions without peripheral hyperinsulinaemia
|
Dunning, B. |
|
2003 |
46 |
supplement-1 |
p. M22-M29 |
article |
7 |
Post-challenge hyperglycaemia is associated with premature death and macrovascular complications
|
Qiao, Q. |
|
2003 |
46 |
supplement-1 |
p. M17-M21 |
article |
8 |
Post-challenge hyperglycaemia is associated with premature death and macrovascular complications
|
Qiao, Q. |
|
2003 |
46 |
supplement-1 |
p. M17-M21 |
article |
9 |
Rationale and options for combination therapy in the treatment of Type 2 diabetes
|
Van Gaal, L. |
|
2003 |
46 |
supplement-1 |
p. M44-M50 |
article |
10 |
Rationale and options for combination therapy in the treatment of Type 2 diabetes
|
Van Gaal, L. |
|
2003 |
46 |
supplement-1 |
p. M44-M50 |
article |
11 |
The mechanisms underlying the unique pharmacodynamics of nateglinide
|
Hu, S. |
|
2003 |
46 |
supplement-1 |
p. M37-M43 |
article |
12 |
The mechanisms underlying the unique pharmacodynamics of nateglinide
|
Hu, S. |
|
2003 |
46 |
supplement-1 |
p. M37-M43 |
article |
13 |
The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications
|
Ceriello, A. |
|
2003 |
46 |
supplement-1 |
p. M9-M16 |
article |
14 |
The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications
|
Ceriello, A. |
|
2003 |
46 |
supplement-1 |
p. M9-M16 |
article |
15 |
The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus
|
Standl, E. |
|
2003 |
46 |
supplement-1 |
p. M30-M36 |
article |
16 |
The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus
|
Standl, E. |
|
2003 |
46 |
supplement-1 |
p. M30-M36 |
article |